Universal admission screening for COVID-19 using quantitative antigen testing and questionnaire screening to prevent nosocomial spread.

ABSTRACT:

Background

In this study, we investigated diagnostic accuracy of quantitative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen testing and whether universal screening was effective to prevent a nosocomial outbreak of coronavirus disease 2019 (COVID-19).

Methods

All adult patients admitted to an acute-care hospital in Tokyo, Japan, after receiving LUMIPULSE SARS-CoV-2 Ag using a nasopharyngeal swab and a brief questionnaire to evaluate symptoms and exposures from December 3, 2020 to March 20, 2021 were included.

Results

Of the 5191 patients, 53 were antigen-positive, 19 were inconclusive and 5119 were negative. The sensitivity and specificity (positive or inconclusive results) of the quantitative antigen test for COVID-19 diagnosis at admission was

SUBMITTER: Morishima M 

PROVIDER: S-EPMC9648767 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature